ARID1A mutation leads to self-inactivation but induces the occurrence of bladder tumors and affects the immune invasion process of bladder cancer, and ARID1A mutation is associated with poor prognosis [162–164]. Here, ARID1A is linked to urinary bladder carcinoma.